Cytokinetics CYTK
NASDAQ CYTK
$63.34 -0.61 (-0.95%)
As of: Oct 21, 2026 · 12:53 PM EDT

Cytokinetics (CYTK) Restructuring Costs (2012)

Updated

Cytokinetics (CYTK) recorded Restructuring Costs of -$56,000 in FY2012, compared with $1.19 million in FY2011.

Analysis

Cytokinetics (CYTK) Restructuring Costs (2012) Analysis & Trends

  • Per Business Quant data, CYTK's Restructuring Costs was $1.19 million in FY2011 and -$23,000 in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.15 Bn 1,101.73 Bn 19.71 Bn
2 Johnson & Johnson 616.41 Bn 534.94 Bn 17.26 Bn
3 AbbVie 501.01 Bn 474.12 Bn 12.70 Bn
4 Merck 367.15 Bn 321.53 Bn 12.21 Bn
5 Novartis Ag 298.00 Bn 261.99 Bn 11.24 Bn
6 Astrazeneca 261.56 Bn 235.25 Bn 12.86 Bn
7 Amgen 235.40 Bn 190.80 Bn 7.24 Bn
8 Gilead Sciences 190.38 Bn 164.57 Bn 6.22 Bn
9 Pfizer 169.76 Bn 116.40 Bn 10.94 Bn
10 Cytokinetics 8.37 Bn 4.54 Bn 25.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 -2,000.00
Jun 30, 2012 -13,000.00
Mar 31, 2012 -41,000.00
API Access

Cytokinetics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=CYTK&period=max&api_key=YOUR_API_KEY